Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miri Krupkin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of General Virology|October 6, 2023
Human immunodeficiency virus 1 5'-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutationsJanin Nouhin, Philip Lei Tzou, Soo-Yon Rhee, et al.
Chembiochem : a European Journal of Chemical Biology|May 2, 2015
A Recombinant Collagen-mRNA Platform for Controllable Protein SynthesisLiping Sun, Yunjing Xiong, Anat Bashan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
HIV-1 5'-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance MutationsJanin Nouhin, Philip L Tzou, Soo-Yon Rhee, et al.
JACS Au|August 30, 2024
CH-π Interactions Are Required for Human Galectin-3 FunctionRoger C Diehl, Rajeev S Chorghade, Allison M Keys, et al.
Structure (London, England : 1993)|July 11, 2017
The Ribosomal Protein uL22 Modulates the Shape of the Protein Exit TunnelItai Wekselman, Ella Zimmerman, Chen Davidovich, et al.
Nucleic Acids Research|July 26, 2022
Uncovering translation roadblocks during the development of a synthetic tRNAArjun Prabhakar, Natalie Krahn, Jingji Zhang, et al.
Nature Communications|January 13, 2026
Intelectin-2 is a broad-spectrum antimicrobial lectinAmanda E Dugan, Deepsing Syangtan, Eric B Nonnecke, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Intelectin-2 is a broad-spectrum antimicrobial lectinAmanda E Dugan, Deepsing Syangtan, Eric B Nonnecke, et al.
Antibiotics (Basel, Switzerland)|July 2, 2016
Ribosomal Antibiotics: Contemporary ChallengesTamar Auerbach-Nevo, David Baram, Anat Bashan, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of General Virology|October 6, 2023
Human immunodeficiency virus 1 5'-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutationsJanin Nouhin, Philip Lei Tzou, Soo-Yon Rhee, et al.
Chembiochem : a European Journal of Chemical Biology|May 2, 2015
A Recombinant Collagen-mRNA Platform for Controllable Protein SynthesisLiping Sun, Yunjing Xiong, Anat Bashan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
HIV-1 5'-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance MutationsJanin Nouhin, Philip L Tzou, Soo-Yon Rhee, et al.
JACS Au|August 30, 2024
CH-π Interactions Are Required for Human Galectin-3 FunctionRoger C Diehl, Rajeev S Chorghade, Allison M Keys, et al.
Structure (London, England : 1993)|July 11, 2017
The Ribosomal Protein uL22 Modulates the Shape of the Protein Exit TunnelItai Wekselman, Ella Zimmerman, Chen Davidovich, et al.
Nucleic Acids Research|July 26, 2022
Uncovering translation roadblocks during the development of a synthetic tRNAArjun Prabhakar, Natalie Krahn, Jingji Zhang, et al.
Nature Communications|January 13, 2026
Intelectin-2 is a broad-spectrum antimicrobial lectinAmanda E Dugan, Deepsing Syangtan, Eric B Nonnecke, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Intelectin-2 is a broad-spectrum antimicrobial lectinAmanda E Dugan, Deepsing Syangtan, Eric B Nonnecke, et al.
Antibiotics (Basel, Switzerland)|July 2, 2016
Ribosomal Antibiotics: Contemporary ChallengesTamar Auerbach-Nevo, David Baram, Anat Bashan, et al.
Pageof 2